Anticoagulation therapy / / edited by Ozcan Basaran, Murat Biteker.
The available parenteral and oral anticoagulants have a large clinical use. Understanding biochemistry of anticoagulants may help to improve therapeutic strategies. Resistance to vitamin K antagonist drugs might be a problem for rodent populations. Patients who have thrombogenic risk factors should...
Saved in:
| TeilnehmendeR: | |
|---|---|
| Place / Publishing House: | Rijeka, Croatia : : IntechOpen,, [2016] ©2016 |
| Year of Publication: | 2016 |
| Language: | English |
| Physical Description: | 1 online resource (140 pages) :; illustrations |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The available parenteral and oral anticoagulants have a large clinical use. Understanding biochemistry of anticoagulants may help to improve therapeutic strategies. Resistance to vitamin K antagonist drugs might be a problem for rodent populations. Patients who have thrombogenic risk factors should be anticoagulated. The need for cardiac implantable electronic devices is increasing, and there is a substantial number of patients who are on oral anticoagulant therapy. Prothrombin complex concentrate and other plasma concentrates are useful to deal with over-coagulated situations. The efficacy and safety of non-vitamin K antagonist oral anticoagulants have been proven in large phase III trials. The real-world data suggest even better outcomes with these agents compared to vitamin K antagonists. |
|---|---|
| ISBN: | 953517309X 9535126679 |
| Access: | Open access |
| Hierarchical level: | Monograph |
| Statement of Responsibility: | edited by Ozcan Basaran, Murat Biteker. |